Dr. Gulick is Principal Investigator of the Cornell Clinical Trials Unit of the National Institutes of Health-funded AIDS Clinical Trials Group (ACTG). His current research focuses on clinical trials of antiretroviral therapy for the treatment and prevention of HIV infection.
